| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.tejnaksh.com | |
| Market Cap | 145.60 Cr. | |
| Enterprise Value(EV) | 145.49 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.49 | Trailing Twelve Months Ending 2022-06 |
| Price-Earning Ratio (PE) | 56.31 | Trailing Twelve Months Ending 2022-06 |
| Industry PE | 47.77 | Trailing Twelve Months Ending 2022-06 |
| Book Value / Share | 20.32 | Trailing Twelve Months Ending 2022-06 |
| Price to Book Value | 6.89 | Calculated using Price: 140.00 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 1.02 Cr. | 10,156,800 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urologyâ€, “Adult Urology (Male, Female)â€, “Andrology and Sexual Dysfunction†and “Nephrology, Dialysis and Renal Transplantâ€. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company's healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female). | ||
| 1 Day |
|
-3.88% |
| 1 Week |
|
-3.01% |
| 1 Month |
|
-4.50% |
| 3 Month |
|
-2.64% |
| 6 Month |
|
-7.25% |
| 1 Year |
|
+45.23% |
| 2 Year |
|
+281.99% |
| 5 Year |
|
+83.99% |
| 10 Year |
|
| 6 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 21.17 | 26.68 | 34.98 | 26.93 | 15.10 | 12.71 | |
| Return on Capital Employed (%) | 34.00 | 29.35 | 32.66 | 27.59 | 17.78 | 14.20 | |
| Return on Assets (%) | 19.32 | 16.96 | 17.97 | 14.93 | 9.10 | 8.36 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
| Shh. Funds | 6 | 8 | 10 | 13 | 15 | 17 | 20 | |
| Non Curr. Liab. | 0 | 7 | 6 | 6 | 7 | 5 | 7 | |
| Curr. Liab. | 0 | 1 | 3 | 2 | 2 | 2 | 2 | |
| Minority Int. | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Equity & Liab. | 7 | 16 | 20 | 22 | 25 | 25 | 30 | |
| Non Curr. Assets | 6 | 14 | 17 | 18 | 18 | 21 | 25 | |
| Curr. Assets | 1 | 2 | 3 | 5 | 7 | 3 | 5 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 7 | 16 | 20 | 22 | 25 | 25 | 30 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
| Net Sales | 5 | 7 | 14 | 20 | 17 | 12 | 12 | |
| Other Income | 0 | 0 | 0 | 2 | 0 | 0 | 0 | |
| Total Income | 5 | 7 | 15 | 21 | 17 | 12 | 13 | |
| Total Expenditure | -2 | -4 | -9 | -16 | -13 | -8 | -8 | |
| PBIDT | 2 | 3 | 6 | 6 | 4 | 4 | 5 | |
| Interest | 0 | -1 | -1 | -1 | -1 | -1 | ||
| Depreciation | 0 | 0 | 0 | -1 | -1 | -1 | -1 | |
| Taxation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Exceptional Items | ||||||||
| PAT | 1 | 2 | 3 | 3 | 2 | 2 | 3 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | |||
| Share Associate | 0 | |||||||
| Other Related Items | ||||||||
| Consolidated Net Profit | 1 | 2 | 3 | 3 | 2 | 2 | 3 | |
| Adjusted EPS | 1 | 2 | 3 | 3 | 2 | 2 | 2 |
| Particulars | 6 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 4 | 2 | 4 | 3 | 1 | 1 | |
| Cash Fr. Inv. | -3 | -8 | -3 | -2 | -1 | 2 | |
| Cash Fr. Finan. | 0 | 6 | -1 | -2 | 0 | -3 | |
| Net Change | 0 | 1 | 1 | -1 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 1 | 2 | 1 | 1 | 1 |
|
Fri, 12 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication In compliance of provision of Regulation 47 read with Regulation 33 of the SEBI (LODR) Regulations 2015 the Company has published the Un-Audited Financial Results for the quarter ended on 30th June 2022 which has been approved by Board of Directors at the Board Meeting held on Thursday 11th August 2022.The financial results were published in Active Times (English Newspaper) and MumbaiLakshadweep (Marathi Newspaper) on 12"August 2022. |
|
Thu, 11 Aug 2022
Board Meeting Outcome for The Outcome Of Board Meeting Held On 11.08.2022 In continuation of our Letter dated 02TH August 2022 We wish to inform you that a meeting of the Boardof Directors of the Company was held on Thursday 11TH August 2022 at A 601 Floor No.6 KailashBusiness Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 at 12.00 p.m. |
|
Thu, 11 Aug 2022
Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30"June 2022. Please find the enclosed herewith Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended on 30" June 2022 along with Limited Review Report thereon approved by the Board of Directors of the Company at its Meeting held on Thursday 11"August 2022 at A 601 Floor No.6 «ailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 at 12.00 p.m. in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| Thu, 18 Aug 2022 |
Close Crossing Last Month Close from Above
|
Making Lower Lows for 3 days
|
High Increase 1 Year
|
High Increase 2 Years
|
Close Crossing 200 SMA From Above
|
Equities
M.F.
Sectors